Search results for : investigators
Juval Aviv: Global expert on fraud and corruption
Thursday 7th February 2019 6:30 PM
Citizens for a better Bahamas present Juval Aviv in two informative and entertaining talks on fraud prevention systems, cyber security, hacking and recovery of stolen funds.
Guest speaker Juval Aviv is an World Renowned Fraud Investigator and Asset Recovery Expert.
See Juval Sizzle. Watch Video Here: https://vimeo.com/181876878/e6e45026bf
Thursday - February 7th, 2019 - 6:30pm
Universit...
Juval Aviv: Global expert on fraud and corruption
Friday 8th February 2019 6:30 PM
Citizens for a better Bahamas present Juval Aviv in two informative and entertaining talks on fraud prevention systems, cyber security, hacking and recovery of stolen funds.
Guest speaker Juval Aviv is an World Renowned Fraud Investigator and Asset Recovery Expert.
See Juval Sizzle. Watch Video Here: https://vimeo.com/181876878/e6e45026bf
Thursday - February 7th, 2019 - 6:30pm
Universit...
Targeting Therapy of Alzheimer's & Related Neurodegenerative Hosted by Fusion Conferences
Saturday 2nd June 2018 6:00 AM
Alzheimer?s disease (AD) is the most common age-dependent neurodegenerative disease, which affects over 5 million people in the US and over 35 million people worldwide. Currently, only four drugs are approved for alleviating symptoms in AD patients, and no new therapy has been approved for AD since 2003. Other related neurodegenerative diseases such as Parkinson?s disease (PD), Huntington?s diseas...
Targeting Therapy of Alzheimer's & Related Neurodegenerative Hosted by Fusion Conferences
Monday 4th June 2018 6:00 AM
Alzheimer?s disease (AD) is the most common age-dependent neurodegenerative disease, which affects over 5 million people in the US and over 35 million people worldwide. Currently, only four drugs are approved for alleviating symptoms in AD patients, and no new therapy has been approved for AD since 2003. Other related neurodegenerative diseases such as Parkinson?s disease (PD), Huntington?s diseas...
Targeting Therapy of Alzheimer's & Related Neurodegenerative Hosted by Fusion Conferences
Sunday 3rd June 2018 6:00 AM
Alzheimer?s disease (AD) is the most common age-dependent neurodegenerative disease, which affects over 5 million people in the US and over 35 million people worldwide. Currently, only four drugs are approved for alleviating symptoms in AD patients, and no new therapy has been approved for AD since 2003. Other related neurodegenerative diseases such as Parkinson?s disease (PD), Huntington?s diseas...
Targeting Therapy of Alzheimer's & Related Neurodegenerative Hosted by Fusion Conferences
Friday 1st June 2018 6:00 AM
Alzheimer?s disease (AD) is the most common age-dependent neurodegenerative disease, which affects over 5 million people in the US and over 35 million people worldwide. Currently, only four drugs are approved for alleviating symptoms in AD patients, and no new therapy has been approved for AD since 2003. Other related neurodegenerative diseases such as Parkinson?s disease (PD), Huntington?s diseas...
Search Options
Filter:
Sponsored Ads
